SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-268920
Filing Date
2019-10-17
Accepted
2019-10-17 08:00:42
Documents
4
Period of Report
2019-12-04
Effectiveness Date
2019-10-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d814474ddef14a.htm DEF 14A 662049
2 GRAPHIC g814474g01t01.jpg GRAPHIC 27531
3 GRAPHIC g814474g64d68.jpg GRAPHIC 12703
4 GRAPHIC g814474g71i24.jpg GRAPHIC 28207
  Complete submission text file 0001193125-19-268920.txt   757650
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31791 | Film No.: 191154035
SIC: 2834 Pharmaceutical Preparations